Position of Teamleader and Leadership Performance

Leadership Clinical Trial

— LeadPos  

Official title:

Effect of the Position of the Teamleader on Quality of Leadership and Team Performance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04824508
• Other study ID #: 4031-Sim
• Status: Completed
• Phase: N/A
• Start date: March 1, 2017
• Est. completion date: September 30, 2022

Study information

• Verified date: November 2022
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.

Description:

participants: physicians taking part in voluntary simulator-based workshops. Teams of 3-4 are formed. One teammember is randomly allocated as teamleader design: prospective, randomized, single-blind, cross-over intervention: teamleaders are randomized and instructed to lead their team from the conventional position at the patient's head or from a remote hands-off position data analysis: will be performed from videorecordings

Recruitment information / eligibility

• Status: Completed
• Enrollment: 151
• Est. completion date: September 30, 2022
• Est. primary completion date: June 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 24 Years and older

Eligibility

Inclusion Criteria:

• Physicians taking part in voluntary workshops

Exclusion Criteria:

• refusal to participate and/or being videorecorded

Related Conditions & MeSH terms

• Leadership

Intervention

Behavioral:
• position
teamleaders are instructed to allocated position

Locations

Country	Name	City	State
Switzerland	University Hospital	Basel	BS

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quantity of leadership	Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire	5 minutes
Secondary	Hands-on time	Hands-on time during the first 5 minutes of the cardiac arrest	5 minutes
Secondary	Quality of leadership	Type of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire	5 minutes